explore | Grilled Cheese

See the latest #LiquidBiopsy research at the ISLB 2026 Poster Tours in Madrid!

📅 7 Nov | 15:15–16:00
📅 8 Nov | 15:00–15:45

Explore new findings, emerging ideas & research from the global community.

𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 → islb-congress.info

#ISLB2026 #CancerResearch #Oncology #Congress

🧬 Facts about Smoldering Multiple Myeloma:

Genomic drivers of progression, APOBEC and AID activity, genomic risk scoring, and MAF/MAFB translocations.

#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #HemeHub

🌟📣 The HemeHub Hematology Summit is almost here!

🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center

Registration is filling quickly. Secure your spot today!

#HemeHub #HemeOnc #Hematology #HematologySummit #MedicalEducation #Oncology

A pleasure to learn more about some IntMed subspecialties from Drs. Noureddine, Milhem, and Davis!

#InternalMedicine #Oncology #Nephrology #AllergyImmunology

[email protected] and @springernature.com will co-host a conference to explore research on cancer therapeutics, highlighting advances in next-generation treatment modalities. #oncology

See more info on our site ➡️: www.onclive.com/view/ut-md-a...

🚀 $MEDS surged 126% overnight to $4.75 following strong after-hours activity, with traders highlighting potential for a price squeeze amid heightened interest and volume. #clinicaltrials #oncology

⚠️ Legionnaires’ disease may be especially deadly in people with cancer.

New findings reveal heightened mortality in this vulnerable population, reinforcing the need for clinical vigilance and prompt recognition. 🫁

#Oncology #InfectiousDiseases

📰 A marketing authorization application for lirafugratinib in previously treated FGFR2-altered metastatic cholangiocarcinoma has been submitted to the EMA. @stanfordmedicine.bsky.social #oncology

See the full story here ➡️: www.onclive.com/view/europea...

Registration takes 30 seconds, registrants get the replay.

us06web.zoom.us/webinar/regi...

#BRAF #mCRC #oncology

🏥Treatment of metastatic breast cancer is shifting in Japan.

Today, the MHLW approved first-line T-DXd plus pertuzumab for HER2+ breast cancer, as well as first-line Dato-DXd for TNBC #bcsm #oncology www.onclive.com/view/japan-a...

Our new #Radiation #Oncology course is now open for enrolment! This 8‑week, self‑directed #eLearning #course covers radiation therapy principles, assessment and management of RT related side effects and adverse effects and more.
Enrol today and start any time.

#Multiomics analysis links #Ferroptosis risk groups to HCC’s immune microenvironment. #GRINA inhibition induces mitochondrial damage & ferroptosis in HCC cells, offering a novel therapeutic strategy. #medsky